Beranda › Kanker Paru Non-Sel Kecil › New York › Queens
Uji klinis Kanker Paru Non-Sel Kecil di Queens, NY
49 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Queens (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 2
- Clinical Research Alliance - Westbury /ID# 270455, Westbury · 14 mi jauhnya
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Menerima pesertaFase 3
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi jauhnya
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
- START New York Long Island LLC, Lake Success · 9 mi jauhnya
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Menerima pesertaFase 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauhnya
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Menerima pesertaFase 2/3
- NYU Langone Hospital Long Island, Mineola · 11 mi jauhnya
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Menerima pesertaFase 3
- New York Cancer & Blood Specialists - New Hyde Park, New Hyde Park · 9 mi jauhnya
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Menerima pesertaFase 3
- Optum Medical Care, PC, Westbury · 14 mi jauhnya
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Menerima pesertaFase 3
- Local Institution - 0224, Laurelton · 5 mi jauhnya
- Optum Medical Care, PC, Westbury · 14 mi jauhnya
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Menerima pesertaFase 3
- Optum Medical Care, PC, Westbury · 14 mi jauhnya
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Research Site, Fresh Meadows · 4 mi jauhnya
- Research Site, Westbury · 14 mi jauhnya
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 2
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi jauhnya
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Menerima pesertaFase 2/3
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi jauhnya
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Menerima pesertaFase 1/2
- START New York, Lake Success · 9 mi jauhnya
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 3
- Research Site, Westbury · 14 mi jauhnya
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
Menerima pesertaFase 1
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi jauhnya
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
Menerima pesertaFase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi jauhnya
Using Urine Samples to Identify Lung Cancer
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi jauhnya
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
Menerima pesertaFase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi jauhnya
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
Menerima pesertaFase 1
- Site 107 - START New York - Long Island, Lake Success · 9 mi jauhnya
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
Menerima pesertaFase 1/2
- NYU Langone Hospital - Long Island, Mineola · 11 mi jauhnya
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success · 9 mi jauhnya
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi jauhnya
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Clinical Research Alliance, Westbury · 14 mi jauhnya
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Menerima pesertaFase 1
- NYU Langone Health - Long Island, Mineola · 11 mi jauhnya
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
Menerima pesertaFase 1
- START NY Long Island, Lake Success · 9 mi jauhnya
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Menerima pesertaFase 1/2
- START New York Long Island, New Hyde Park · 9 mi jauhnya
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Menerima pesertaFase 1
- Perlmutter Cancer Center at NYU Langone Hospital Long Island, Mineola · 11 mi jauhnya
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Menerima peserta
- Memorial Sloan Kettering Nassau (Limited protocol activities), Rockville Centre · 10 mi jauhnya
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Menerima pesertaFase 3
- Northwell Health/R.J. Zuckerberg Cancer Center, Lake Success · 9 mi jauhnya
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Menerima pesertaFase 3
- NYU Langone Hospital - Long Island, Mineola · 11 mi jauhnya
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauhnya
A Study of MGC026 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- START-New York Long Island, Lake Success · 9 mi jauhnya
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
Menerima pesertaFase 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauhnya
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Menerima pesertaFase 1/2
- Northwell Health, Lake Success · 9 mi jauhnya
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Menerima pesertaFase 3
- Queens Cancer Center, Rego Park · 3 mi jauhnya
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi jauhnya
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
Menerima pesertaFase 1/2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi jauhnya
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer
Menerima pesertaStudi observasional
- Memorial Sloan Kettering Nassau (Consent Only), Uniondale · 13 mi jauhnya
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Menerima pesertaFase 1
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park · 9 mi jauhnya
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon · 27 mi jauhnya
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Menerima pesertaFase 1/2
- Clinical Research Alliance, Westbury · 14 mi jauhnya
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Menerima pesertaFase 3
- New York Cancer & Blood Specialists (NYCBS), New Hyde Park · 9 mi jauhnya
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Menerima pesertaFase 1
- START New York Long Island, LLC, Lake Success · 9 mi jauhnya
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- START New York Long Island, LLC, Lake Success · 9 mi jauhnya
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
Menerima pesertaFase 1/2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi jauhnya
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 2
- Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre · 10 mi jauhnya
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauhnya
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
Menerima pesertaFase 1/2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · 10 mi jauhnya
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer
Menerima pesertaFase 2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi jauhnya
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- Queens Hospital Center, Jamaica · 2 mi jauhnya
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Menerima pesertaFase 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauhnya
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
Menerima pesertaFase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10 mi jauhnya
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Hempstead · 12 mi jauhnya
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Studi lain di Queens
- Kanker Payudara64 studi
- Kanker Kolorektal31 studi
- Kanker Metastatik28 studi
- Kanker Ovarium28 studi
- Kanker Prostat27 studi
- Kanker (semua jenis)26 studi
- Kanker Endometrium25 studi
- Kanker Paru22 studi
- Leukemia Mieloid Akut21 studi
- Mieloma Multipel20 studi
- Kanker Pankreas20 studi
- Karsinoma Sel Skuamosa Kepala dan Leher20 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.